TELMIN-AM
TELMIN-AM is a fixed-dose pharmaceutical tablet formulation containing Telmisartan 40 mg and Amlodipine 5 mg. The composition is documented in the supplied Suprimeda product information under the cardiac and antihypertensive product category. Telmisartan belongs to the angiotensin II receptor blocker (ARB) class, while Amlodipine belongs to the dihydropyridine calcium channel blocker class. The combination of these two active pharmaceutical ingredients is available as an oral tablet formulation in the 40 mg/5 mg strength. Official pharmaceutical labeling also recognizes Telmisartan and Amlodipine 40 mg/5 mg as an established fixed-dose tablet combination.
Everything You, Need to Know
TELMIN-AM is presented in a blister-pack format, and the product carton shown in the supplied image specifies a pack size of 10 × 10 tablets.
TELMIN-AM is an oral tablet formulation containing a fixed combination of Telmisartan 40 mg and Amlodipine 5 mg. The 40 mg/5 mg combination is also recognized in official pharmaceutical labeling.
TELMIN-AM contains Telmisartan 40 mg and Amlodipine 5 mg as its active pharmaceutical ingredients. This composition is listed in the supplied Suprimeda product document.